Shanghai Hile Bio-Technology Co.,Ltd.’s Net Profit Rose 26.7% in First Three Quarters of 2022

Shanghai Hile Bio-Technology Co.,Ltd. (上海海利生物技术股份有限公司) (603718.SH) reported a net profit of 40.8 million yuan in the first three quarters of 2022, up 26.7% year-on-year.

Meanwhile, the company posted 272.4 million yuan in revenue, up 1.9% year-on-year.

At the end of the reporting period, it had 2 billion yuan in total assets and 949.6 million yuan in total liabilities, with a liability-to-asset ratio of 48.1%.